Funding Opportunity RFA-DK-22-507 from the NIH Guide for Grants and Contracts. This FOA invites a cooperative agreement application to renew the APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO) Scientific Data Research Center (SDRC), with a continued charge to coordinate the clinical and research efforts of the APOLLO Consortium. This FOA runs in parallel with a separate FOA that invites applications for the APOLLO Clinical Centers (CCs) (RFA-DK-221-506). The APOLLO Network study results are expected to enhance understanding of associations of APOL1 genotype with renal transplant outcomes and provide evidence for optimizing allocation and management approaches to kidney donation in individuals of African ancestry.

Competitive : The Francis Crick Institute: We are looking to recruit a Bioinformatician to run and develop the Institute’s NGS data processing and analysis pipeline infrastructure. London (Central), London (Greater) (GB)

Notice NOT-AT-22-032 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-122 from the NIH Guide for Grants and Contracts

Notice NOT-OH-22-009 from the NIH Guide for Grants and Contracts

Notice NOT-OH-22-008 from the NIH Guide for Grants and Contracts

Notice NOT-OH-22-007 from the NIH Guide for Grants and Contracts

Notice NOT-DA-22-072 from the NIH Guide for Grants and Contracts

Notice NOT-DA-22-067 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-EB-22-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to develop clinical-grade prototypes intended for use as safe, effective, and non-addictive device-based technologies and approaches to treat pain. The goal of the program is to demonstrate treatment using credible neural targets for device-based interventions and/or diagnostics for pain, building upon the latest mechanistic knowledge about the anatomy and physiology of central, spinal, and peripheral pathways involved in pain. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

£55000 - £65000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Head of Data Management and Systems to join a leading Life Sciences organisation based in the Cambridgeshire area. As... Cambridgeshire

Funding Opportunity RFA-OH-23-001 from the NIH Guide for Grants and Contracts. NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B, of the James Zadroga 9/11 Health and Compensation Act of 2010 (Public Law 111347, as amended by Public Laws 114113 and 11659).

Funding Opportunity RFA-DK-22-506 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to renew the APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO) Clinical Centers (CCs), with a continued charge to determine laboratory parameters and clinical events in the kidney transplant recipients, according to the clinical and research efforts of the APOLLO Consortium. This FOA runs in parallel with a separate FOA that invites applications for the APOLLO SDRC (SDRC) (RFA-DK-22-507). The APOLLO Network study results are expected to enhance understanding of the associations of APOL1 genotype with renal transplant outcomes and provide evidence for optimizing allocation and management approaches to kidney donation in individuals of African Ancestry.

Notice NOT-DA-23-005 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-053 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-052 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HS-22-010 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) will award National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible domestic institutions to enhance predoctoral and postdoctoral research training and ensure that a diverse and highly trained workforce is available and committed to the generation, translation and dissemination of new scientific evidence and analytical tools that will be used to improve health care delivery in the United States. AHRQ expects that the proposed research training programs will incorporate didactic, research and career development elements to prepare individuals for careers that will have a significant impact on the health care needs of the Nation.

Notice NOT-AI-22-066 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-23-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. This FOA is intended to provide support for the further development of projects where preliminary data supports the feasibility of the line of investigation. Applicants without preliminary data may wish to apply to the companion R21 FOA (RFA-HD-23-025).

Funding Opportunity RFA-HD-23-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. High risk/high reward projects that lack preliminary data may be most appropriate for this FOA. Applicants with preliminary data may wish to apply to the companion R01 mechanism (RFA-HD-23-024).